Adverse drug reactions in medical intensive care unit of a tertiary care hospital

被引:33
作者
Joshua, Lisha [1 ]
Devi, Padmini [2 ]
Guido, Shoba [2 ]
机构
[1] Tata Mem Hosp, Nutr Clin, Dept Gastrointestinal Dis, Bombay 400012, Maharashtra, India
[2] St Johns Med Coll, Dept Pharmacol, Bangalore, Karnataka, India
关键词
adverse drug reactions; medical ICU; acute renal failure; EVENTS;
D O I
10.1002/pds.1761
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose Patients in the intensive care unit (ICU) have multiorgan dysfunction as well as altered pharmacokinetic parameters. Hence they are susceptible to adverse drug reactions (ADRs). The objective of the study is to assess the characteristics of ADRs among inpatients in the medical ICU and to compare the same with patients who have not experienced ADRs. Methods Prospective, observational study for a period of 1 year in medical ICU of a tertiary care hospital. Relevant data of patients with ADRS were analysed. Characteristics of patients with and without ADRs were compared. Results Of 728 patients admitted in medical ICU, 222 (28.4%) had ADRs. Multiple ADRs (38.7%) implicated by the same drug and serious ADRs (37%) were noticed. Renal/electrolyte system (21%) was most commonly involved. Clinical spectrum included acute renal failure (ARF, 11.4%), hepatic injuries (5.4%), haematological dysfunction (4.2%), seizures (3.3%), upper gastrointestinal bleed (3.3%) and cutaneous ADRs (3.3%). Antimicrobials (27%) were the commonly implicated drug class. The most commonly implicated drug was furosemide (6.8%). Infrequently reported ADRs included azithromycin-induced erythema multiforme, leflunamide-induced erythema multiforme and vasculitis, ceftazidime-induced seizures and ceftriaxone-induced hepatitis. Co-morbidity, polypharmacy and duration of stay were significantly higher in patients with ADRs compared to those who have not experienced ADRs. Three patients died. Conclusion High incidence of serious and multiple ADRs noticed. A wide clinical spectrum of ADRs and infrequently reported ADRs to newer drugs were also observed. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:639 / 645
页数:7
相关论文
共 17 条
[1]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[2]  
Biradar V, 2004, Indian J Nephrol, V14, P93
[3]   Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units [J].
Cullen, DJ ;
Sweitzer, BJ ;
Bates, DW ;
Burdick, E ;
Edmondson, A ;
Leape, LL .
CRITICAL CARE MEDICINE, 1997, 25 (08) :1289-1297
[4]   Incidence and costs of adverse drug reactions during hospitalisation - Computerised monitoring versus stimulated spontaneous reporting [J].
Dormann, H ;
Muth-Selbach, U ;
Krebs, S ;
Criegee-Rieck, M ;
Tegeder, I ;
Schneider, HT ;
Hahn, EG ;
Levy, M ;
Brune, K ;
Geisslinger, G .
DRUG SAFETY, 2000, 22 (02) :161-168
[5]   Failure mode and effects analysis application to critical care medicine [J].
Duwe, B ;
Fuchs, BD ;
Hansen-Flaschen, J .
CRITICAL CARE CLINICS, 2005, 21 (01) :21-+
[6]   Adverse drug reactions: definitions, diagnosis, and management [J].
Edwards, IR ;
Aronson, JK .
LANCET, 2000, 356 (9237) :1255-1259
[7]   Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine [J].
Fattinger, K ;
Roos, M ;
Vergères, P ;
Holenstein, C ;
Kind, B ;
Masche, U ;
Stocker, DN ;
Braunschweig, S ;
Kullak-Ublick, GA ;
Galeazzi, RL ;
Follath, F ;
Gasser, T ;
Meier, PJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (02) :158-167
[8]  
GILL SK, 2006, CRIT CARE CLIN, V22, P273
[9]  
GILL SK, 2006, AM J HEALTH-SYST PH, V63, P1876
[10]  
Krähenbühl-Melcher A, 2007, DRUG SAFETY, V30, P379